Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLASSIFY: Insulin Lispro Mix25 vs Mix50 in T2DM
NCT01773473Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2013
- Primary completion
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 4 trial of insulin lispro in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Jan 2013; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01773473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01773473.